Evidence map›Paper›PMID 28817576›Full record

ArticlePloS one2017

Gestational diabetes mellitus is associated with increased pro-migratory activation of vascular endothelial growth factor receptor 2 and reduced expression of vascular endothelial growth factor receptor 1.

Felipe Troncoso, Jesenia Acurio, Kurt Herlitz, Claudio Aguayo, Patricio Bertoglia, Enrique Guzman-Gutierrez, Marco Loyola, Marcelo Gonzalez, Meriem Rezgaoui, Gernot Desoye and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Observational
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Felipe TroncosoVascular Physiology Laboratory, Group of Investigation in Tumor Angiogenesis (GIANT), Chillán, Chile.
Jesenia AcurioVascular Physiology Laboratory, Group of Investigation in Tumor Angiogenesis (GIANT), Chillán, Chile.
Kurt HerlitzVascular Physiology Laboratory, Group of Investigation in Tumor Angiogenesis (GIANT), Chillán, Chile.
Claudio AguayoDepartment of Clinical Biochemistry and Immunology, Faculty of Pharmacy, University of Concepción, Concepción, Chile.
Patricio BertogliaObstetric and Gynecology Department, Hospital Clinico Herminda Martin, Chillán, Chile.
Enrique Guzman-GutierrezGroup of Research and Innovation in Vascular Health (GRIVAS Health), Chillan, Chile.
Marco LoyolaFacultad de Ciencias de la Salud, Universidad San Sebastián, Concepción, Chile.
Marcelo GonzalezVascular Physiology Laboratory, Department of Physiology, Faculty of Biological Sciences, Universidad de Concepción, Concepción, Chile.
Meriem RezgaouiDepartment of Basic Sciences, Universidad del Bío-Bío, Chillán, Chile.
Gernot DesoyeDepartment of Obstetrics and Gynaecology, Medical University of Graz, Graz, Austria.
Carlos EscuderoVascular Physiology Laboratory, Group of Investigation in Tumor Angiogenesis (GIANT), Chillán, Chile.ORCID http://orcid.org/0000-0001-7688-4621
University of Bío-Bío · CLSan Sebastián University · CLUniversity of Concepción · CLMedical University of Graz · ATUniversidad Católica de la Santísima Concepción · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Placentas from gestational diabetes mellitus (GDM) are often hypervascularized; however, participation of vascular endothelial growth factor (VEGF) and its receptors in this placental adaptation is unclear. We aimed to test whether changes in phosphorylation of tyrosine 951 or tyrosine 1175 (pY951 or pY1175) of the vascular endothelial growth factor receptor 2 (KDR) are associated with the proangiogenic state observed in placentas from GDM. We obtained placental samples from women with normal pregnancies (n = 24) or GDM (n = 18). We measured the relative expression of markers for endothelial cell number (CD31, CD34), VEGF, vascular endothelial growth factor receptor 1 (Flt-1), KDR, pY951 and pY1175 of KDR in placental homogenate. Immunohistochemistry of placental blood vessels were performed using CD34. Proliferation and migration of human umbilical vein endothelial cells (HUVEC) obtained from normal pregnancy and GDM were determined in absence or presence of conditioned medium (CM) harvested from GDM or normoglycemic HUVEC cultures. GDM was associated with more CD31 and CD34 protein compared to normal pregnancy. High number, but reduced area of placental blood vessels was found in GDM. Reduced Flt-1 levels (mRNA and protein) are associated with reduced KDR mRNA, but higher KDR protein levels in placentas from GDM. No significant changes in Y951-or Y1175-phosphorylation of KDR in placentas from GDM were found. GDM did not alter proliferation of HUVECs, but enhanced migration. Conditioned medium harvested from GDM HUVEC cultures enhanced KDR protein amount, tube formation capacity and cell migration in HUVEC isolated from normoglycemic pregnancies. The data indicate that GDM is associated with reduced expression of Flt-1 but high pro-migratory activation of KDR reflecting a proangiogenic state in GDM.

Indexed as

Cell MovementAdultAntigens, CD34BiomarkersCells, CulturedDiabetes, GestationalFemaleHumansHuman Umbilical Vein Endothelial CellsInfant, NewbornMalePlacentaPlatelet Endothelial Cell Adhesion Molecule-1PregnancyVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-1Antigens, CD34BiomarkersFLT1 protein, humanKDR protein, humanPlatelet Endothelial Cell Adhesion Molecule-1Vascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-1Vascular Endothelial Growth Factor Receptor-2

Identifiers

PMID28817576
PMCPMC5560693
OpenAlexW2746965008

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.